ArticleEuropean journal of medical research2026

PEAK1 promotes prostate cancer progression and docetaxel resistance by mediating the polarization of tumor-associated macrophages.

Jianxin Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.